HLVX
Price
$2.09
Change
-$0.01 (-0.48%)
Updated
Sep 16 closing price
Capitalization
104.76M
43 days until earnings call
IPHYF
Price
$2.00
Change
+$0.38 (+23.46%)
Updated
Sep 12 closing price
Capitalization
170.91M
Interact to see
Advertisement

HLVX vs IPHYF

Header iconHLVX vs IPHYF Comparison
Open Charts HLVX vs IPHYFBanner chart's image
HilleVax
Price$2.09
Change-$0.01 (-0.48%)
Volume$2.8M
Capitalization104.76M
Innate Pharma
Price$2.00
Change+$0.38 (+23.46%)
Volume$24.86K
Capitalization170.91M
HLVX vs IPHYF Comparison Chart in %
Loading...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLVX vs. IPHYF commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLVX is a Hold and IPHYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (HLVX: $2.09 vs. IPHYF: $2.00)
Brand notoriety: HLVX and IPHYF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLVX: 257% vs. IPHYF: 539%
Market capitalization -- HLVX: $104.76M vs. IPHYF: $170.91M
HLVX [@Biotechnology] is valued at $104.76M. IPHYF’s [@Biotechnology] market capitalization is $170.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLVX’s FA Score shows that 1 FA rating(s) are green whileIPHYF’s FA Score has 0 green FA rating(s).

  • HLVX’s FA Score: 1 green, 4 red.
  • IPHYF’s FA Score: 0 green, 5 red.
According to our system of comparison, HLVX is a better buy in the long-term than IPHYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLVX’s TA Score shows that 2 TA indicator(s) are bullish while IPHYF’s TA Score has 3 bullish TA indicator(s).

  • HLVX’s TA Score: 2 bullish, 4 bearish.
  • IPHYF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, IPHYF is a better buy in the short-term than HLVX.

Price Growth

HLVX (@Biotechnology) experienced а 0.00% price change this week, while IPHYF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

HLVX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHYF($171M) has a higher market cap than HLVX($105M). HLVX YTD gains are higher at: 0.966 vs. IPHYF (-31.034).
HLVXIPHYFHLVX / IPHYF
Capitalization105M171M61%
EBITDA-66.58MN/A-
Gain YTD0.966-31.034-3%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash160MN/A-
Total Debt23.5MN/A-
FUNDAMENTALS RATINGS
IPHYF: Fundamental Ratings
IPHYF
OUTLOOK RATING
1..100
99
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLVXIPHYF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
45%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
46%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
50%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 29 days ago
78%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRBCF346.00N/A
N/A
Virbac SA
HBUV1.30N/A
N/A
Hubilu Venture Corporation
SHVTF3.35N/A
N/A
Select Harvests Ltd.
NEMKY24.85N/A
N/A
NEMETSCHEK SE
MMVVF0.03N/A
N/A
MultiMetaVerse Holdings Limited

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
N/A
FBIOP - HLVX
81%
Closely correlated
-1.08%
BRIBF - HLVX
58%
Loosely correlated
N/A
DNLI - HLVX
47%
Loosely correlated
-2.03%
NTLA - HLVX
45%
Loosely correlated
-1.04%
IPSC - HLVX
44%
Loosely correlated
+1.13%
More

IPHYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHYF has been loosely correlated with MBIO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHYF jumps, then MBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHYF
1D Price
Change %
IPHYF100%
N/A
MBIO - IPHYF
42%
Loosely correlated
-4.29%
HLVX - IPHYF
38%
Loosely correlated
N/A
SLRX - IPHYF
33%
Loosely correlated
+1.91%
RVMD - IPHYF
30%
Poorly correlated
-0.46%
GRI - IPHYF
28%
Poorly correlated
-2.50%
More